U.S. STOCKS Autodesk, Aaron's Company
Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: https://refini.tv/3LI4BU7
The Morning News Call newsletter: https://refini.tv/3dKUyB8
Futures tracking Wall Street's main indexes were mixed in muted trading on Monday as investors awaited fresh economic data and comments from Federal Reserve officials throughout the week for more clarity on monetary policy. .N
At 9:03 ET, Dow e-minis 1YMc1 were down 0.26% at 38,505. S&P 500 e-minis ESc1 were down 0.12% at 5,430.75, while Nasdaq 100 e-minis NQc1 were up 0.01% at 19,687.25.
The top three NYSE percentage gainers premarket .PRPG.NQ:
** Allego Nv Ord <ALLG.K>, up 129.9%
** The Aarns Co Ord <AAN>, up 32.2%
** Primo Water Ord <PRMW.K>, up 12.5%
The top three NYSE percentage losers premarket .PRPL.NQ:
** Belden Inc <BDC>, down 15.5%
** Ampco Pittsburgh <AP>, down 9.6%
** Cs Disco Inc Ord <LAW>, down 9.6%
The top three Nasdaq percentage gainers premarket .PRPG.O:
** Mustang Bio Inc <MBIO.O>, up 189.2%
** Company name not found <SCNI.O>, up 77.7%
** Interactive Strength Inc <TRNR.O>, up 60.3%
The top three Nasdaq percentage losers premarket .PRPL.O:
** Aerovate Therapeutics Inc <AVTE.O>, down 90.7%
** Ovid Therapeutics Inc <OVID.O>, down 65.3%
** Company name not found <OCEAW.O>, down 50%
** Autodesk Inc ADSK.O: up 4.6% premarket
BUZZ - Gains after report Starboard Value takes about $500 mln stake nL4N3IF0IZ
** Ollie's Bargain Outlet Holdings Inc OLLI.O: up 2.8% premarket
BUZZ - Up after JP Morgan upgrades to 'overweight' nL4N3IF0M2
** Fate Therapeutics Inc FATE.O: up 6.6% premarket
BUZZ - Piper Sandler raises Fate to 'overweight' on disease treatment progress nL4N3IF0MO
** Aaron's Company Inc AAN.N: up 32.2% premarket
BUZZ - Jumps on take-private deal with IQVentures nL4N3IF0NT
** Rio Tinto PLC RIO.N: down 1.5% premarket ** BHP Group Ltd BHP.N: down 2.1% premarket ** Southern Copper Corp SCCO.N: down 1.9% premarket ** Freeport-McMoRan Inc FCX.N: down 1.4% premarket BUZZ - US shares of copper miners fall after weak Chinese factory data nL4N3IF0OA
** Marinus Pharmaceuticals Inc MRNS.O: down 8.5% premarket
BUZZ - Down after seizure treatment fails to meet a key late-stage study goal nL4N3IF0O7
** AMC Networks Inc AMCX.O: down 12.2% premarket
BUZZ - Slides on convertible debt deal plans nL1N3IF0AG
** Ovid Therapeutics Inc OVID.O: down 65.3% premarket
BUZZ - Plummets after Takeda's drug fails in late-stage studies nL4N3IF0P9
** Zymeworks Inc ZYME.O: up 6.4% premarket
BUZZ - Gains on FDA nod for study of cancer therapy in humans nL4N3IF0SO
** Best Buy Co Inc BBY.N: up 4.0% premarket
BUZZ - Rises after report UBS turns bullish nL1N3IF0CK
(Compiled by Rajarshi Roy and Abhinav Parmar)
</body></html>Aloqador aktivlar
Eng oxirgi yangiliklar
Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.
Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi
Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.
